Recent Posts
- Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
- Dr. Michelle LeRoux Williams Earns Washington Business Journal’s Medical Device Innovator Award
- New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices
- Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
- Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method